Cargando…

Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat

Epigenetic regulation of gene transcription by small molecule inhibitors of histone deacetylases (HDAC) is a novel cancer therapy. Vorinostat (Zolinza(™)) is the first FDA approved HDAC-inhibitor for treatment of patients with cutaneous T cell lymphoma (CTCL) who have progressive, persistent or recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Duvic, Madeleine, Vu, Jenny
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721288/
https://www.ncbi.nlm.nih.gov/pubmed/19707308